Immunovia AB(GB:0G8X)
kr 0.040.00 (0.00%)
GB:0G8X
Immunovia AB financials statements
kr 0.04
At close:0.00 (0.00%)
Immunovia AB (0G8X) Financial Statements
1 Followers
Immunovia AB Financial Overview
Immunovia AB's market cap is currently kr87.50M. The company's EPS TTM is kr-0.12; its P/E ratio is -0.26; Immunovia AB is estimated to report earnings on February 11, 2027, and the estimated EPS forecast is kr-0.01. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 685.00K | kr 931.00K | kr 1.57M | kr 1.15M | kr 844.00K |
| Gross Profit | kr -79.50M | kr 931.00K | kr -5.11M | kr -3.07M | kr 15.81M |
| Operating Income | kr -79.50M | kr -109.41M | kr -296.46M | kr -191.15M | kr -166.74M |
| EBITDA | kr -77.18M | kr -61.27M | kr -166.56M | kr -141.58M | kr -135.47M |
| Net Income | kr -145.91M | kr -76.54M | kr -309.44M | kr -145.03M | kr -157.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 77.46M | kr 25.32M | kr 76.79M | kr 106.04M | kr 287.41M |
| Total Assets | kr 88.21M | kr 33.04M | kr 98.68M | kr 300.59M | kr 493.81M |
| Total Debt | kr 857.00K | kr 680.00K | kr 4.29M | kr 37.57M | kr 33.26M |
| Net Debt | kr -76.60M | kr -24.64M | kr -72.50M | kr -68.47M | kr -254.14M |
| Total Liabilities | kr 23.48M | kr 21.39M | kr 31.69M | kr 56.79M | kr 59.91M |
| Stockholders' Equity | kr 64.73M | kr 11.65M | kr 66.99M | kr 243.80M | kr 433.90M |
| Cash Flow | |||||
| Free Cash Flow | kr -78.40M | kr -96.75M | kr -148.12M | kr -177.21M | kr -176.83M |
| Operating Cash Flow | kr -78.40M | kr -96.75M | kr -147.06M | kr -175.58M | kr -152.65M |
| Investing Cash Flow | kr -5.69M | kr 0.00 | kr 3.20M | kr -1.62M | kr -23.83M |
| Financing Cash Flow | kr 136.82M | kr 44.81M | kr 114.74M | kr -5.11M | kr -5.27M |
Currency in SEK
